Literature DB >> 30838396

Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis.

Yanling Gou1, Xue Li1, Peiling Li1, Hongyan Zhang1, Tenghan Xu1, Hao Wang1, Beidi Wang1, Xuesong Ma1, Xue Jiang1, Zongfeng Zhang1.   

Abstract

STUDY QUESTION: How is the activation of estrogen receptor β (ERβ) in endometriotic stromal cells (ESCs) involved in macrophage recruitment to promote the pathogenesis of endometriosis? SUMMARY ANSWER: ERβ modulates the production of C-C motif chemokine ligand 2 (CCL2) via nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling in ESCs and thus recruits macrophages to ectopic lesions to promote pathogenesis. WHAT IS KNOWN ALREADY: Macrophages are mainly recruited to the peritoneal cavity to promote the pathogenesis of endometriosis. Recent studies have demonstrated that ERβ plays an important role in the progression of endometriosis through modulating apoptosis and inflammation. STUDY DESIGN, SIZE, DURATION: An observational study consisting of 22 cases (women with endometriosis, diagnosed by laparoscopy and histological analysis) and 14 controls (without endometriosis) was carried out. PARTICIPANTS/MATERIALS, SETTING,
METHODS: Tissues and stromal cells that were isolated from 22 patients with ovarian endometrioma and deeply infiltrating endometriosis were compared with tissues and stromal cells from 14 patients with normal cycling endometrium using immunohistochemistry, quantitative PCR, Western blot, cell migration assay and cloning formation assay. P values < 0.05 were considered significant, and experiments were repeated in at least three different cell preparations. MAIN RESULTS AND THE ROLE OF CHANCE: We observed that accumulated macrophages were recruited to the ectopic milieu and mainly adopted an alternatively activated macrophage (M2) phenotype. To reveal the underlying mechanism for this, we conducted a series of experiments and found that high expression of ERβ led to the production of CCL2 via NF-κB signaling and macrophages were recruited to the ectopic milieu. An in vitro co-culture assay also suggested that the recruited macrophages in turn could promote the proliferation and clonogenic ability of ESCs. Overall, the activation of ERβ in ESCs is involved in macrophage recruitment via NF-κB/CCL2 signaling and subsequently appears to promote the pathogenesis of endometriosis. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: Due to the limitations of obtaining surgical specimens, endometrioma tissues were collected mainly from women diagnosed with middle to late stage endometriosis. We identified the predominant presence of M2 macrophages in the samples used in our study, but the underlying mechanism of how recruited macrophages acquire the M2 phenotype is undefined. WIDER IMPLICATIONS OF THE
FINDINGS: This work provides novel insight into the mechanism by which ERβ may modulate macrophage infiltration and promote pathogenesis, which may provide a new therapeutic target for endometriosis. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the National Natural Science Foundation of China (81671430). The authors have no conflicts of interest.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CCL2; endometriosis; endometriotic stromal cell; estrogen receptor beta; macrophage

Mesh:

Substances:

Year:  2019        PMID: 30838396     DOI: 10.1093/humrep/dez019

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  18 in total

Review 1.  A systematic review of toll-like receptors in endometriosis.

Authors:  Bruna Cestari de Azevedo; Fernanda Mansur; Sérgio Podgaec
Journal:  Arch Gynecol Obstet       Date:  2021-04-29       Impact factor: 2.344

2.  Free large sized intra-abdominal endometrioma in a postmenopausal woman: a case report.

Authors:  Antoine Naem; Anwar Shamandi; Ali Al-Shiekh; Bayan Alsaid
Journal:  BMC Womens Health       Date:  2020-09-03       Impact factor: 2.809

3.  Macrophage-derived netrin-1 contributes to endometriosis-associated pain.

Authors:  Shaojie Ding; Xinyue Guo; Libo Zhu; Jianzhang Wang; Tiantian Li; Qin Yu; Xinmei Zhang
Journal:  Ann Transl Med       Date:  2021-01

4.  Kiwi Root Extract Inhibits the Development of Endometriosis in Mice by Downregulating Inflammatory Factors.

Authors:  Tingting Liao; Shenzhi Zhao; Tong Zhou; Jiajia Song; Xianping Huang; Huiqiu Xiang; Yanyan Lin; Jiajia Chen; Zhangye Xu
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-26       Impact factor: 2.629

Review 5.  Brassica Bioactives Could Ameliorate the Chronic Inflammatory Condition of Endometriosis.

Authors:  Paula García-Ibañez; Lucía Yepes-Molina; Antonio J Ruiz-Alcaraz; María Martínez-Esparza; Diego A Moreno; Micaela Carvajal; Pilar García-Peñarrubia
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

6.  Platelets and Regulatory T Cells May Induce a Type 2 Immunity That Is Conducive to the Progression and Fibrogenesis of Endometriosis.

Authors:  Fengyi Xiao; Xishi Liu; Sun-Wei Guo
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

7.  IL-17A Modulates Peritoneal Macrophage Recruitment and M2 Polarization in Endometriosis.

Authors:  Jessica E Miller; Soo Hyun Ahn; Ryan M Marks; Stephany P Monsanto; Asgerally T Fazleabas; Madhuri Koti; Chandrakant Tayade
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

Review 8.  Abdominal wall endometriosis (a narrative review).

Authors:  Mara Carsote; Dana Cristiana Terzea; Ana Valea; Ancuta-Augustina Gheorghisan-Galateanu
Journal:  Int J Med Sci       Date:  2020-02-10       Impact factor: 3.738

Review 9.  Autonomic nervous system and inflammation interaction in endometriosis-associated pain.

Authors:  Yajing Wei; Yanchun Liang; Haishan Lin; Yujing Dai; Shuzhong Yao
Journal:  J Neuroinflammation       Date:  2020-03-07       Impact factor: 8.322

10.  M2 macrophages reduce the effect of gefitinib by activating AKT/mTOR in gefitinib-resistant cell lines HCC827/GR.

Authors:  Fengqi Xiao; Ni Liu; Xinchun Ma; Jing Qin; Yanguo Liu; Xiuwen Wang
Journal:  Thorac Cancer       Date:  2020-09-21       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.